guselkumab - Robuta Search

https://www.biospace.com/morphosys-s-licensee-janssen-announces-top-line-phase-3-results-for-guselkumab-tremfya-r-in-adults-with-active-psoriatic-arthritis MorphoSys's Licensee Janssen Announces Top-line Phase 3 Results for Guselkumab (Tremfya(R)) in... https://www.jnj.com/innovativemedicine/emea/media-center/press-releases/tremfya-guselkumab-receives-positive-chmp-opinion-for-subcutaneous-induction-regimen-in-ulcerative-colitis-a-first-for-an-il-23-inhibitor TREMFYA (guselkumab) receives positive CHMP opinion for subcutaneous induction regimen in... Sep 22, 2025 - Recommendation based on the findings from the Phase 3 ASTRO study in ulcerative colitis.1,2,3 Guselkumab has the potential to become the first IL-23 inhibitor... tremfya guselkumab receives positive chmp https://www.news-medical.net/news/20260327/Guselkumab-shows-minor-added-benefit-for-specific-Crohns-disease-patients.aspx Guselkumab shows minor added benefit for specific Crohn's disease patients Mar 27, 2026 - The human monoclonal antibody guselkumab has been approved for certain adults with moderately to severely active ulcerative colitis since April 2025. crohn s disease guselkumab shows minor added https://www.tga.gov.au/resources/artg/460503 TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial (460503) |... Dec 11, 2025 - Australian Register of Therapeutic Goods (ARTG) information for TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial. https://www.wam.ae/en/article/bj7h69s-emirates-drug-establishment-approves-new Emirates Drug Establishment approves new indications for 'Guselkumab' for treating patients with... The Emirates Drug Establishment (EDE) has approved new indications for Guselkumab, making the UAE the second country globally to authorise the treatment for... emirates drug establishment approves new https://www.cigna.com/knowledge-center/hw/medications/guselkumab-injection-a617036 Guselkumab Injection | Cigna Guselkumab injection is used to treat: plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) psoriatic arthritis (a... guselkumab injection cigna https://www.news-medical.net/news/20250718/Research-highlights-guselkumabs-impact-on-Crohns-endoscopic-healing.aspx Research highlights guselkumab's impact on Crohn's endoscopic healing Jul 18, 2025 - In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a... research highlights guselkumab impact crohn endoscopic https://rheumatology.org/patients/guselkumab-tremfya Guselkumab (Tremfya) | American College of Rheumatology Guselkumab is a biologic medication used to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It... american college guselkumab tremfya rheumatology https://www.affaritaliani.it/medicina/artrite-psoriasica-janssen-comunica-nuovi-dati-su-guselkumab-677831.html Artrite psoriasica: Janssen comunica nuovi dati su Guselkumab Jun 10, 2020 - Gli studi di fase 3, DISCOVER-1 e DISCOVER-2 presentati al congresso europeo di Reumatologia EULAR 2020 artrite psoriasica janssen comunica nuovi dati